Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Aditi Ganguly

3 Healthtech Stocks Wall Street Predicts Will Rally More Than 40% or More: GoodRx, 23andMe, and Exact Sciences

Healthtech gained traction since the onset of the COVID-19 pandemic two years ago, as the demand for telemedicine and digital healthcare rose. With aging populations, increasing lifestyle diseases given the continuing remote lifestyle, and increasing costs, healthcare providers are innovating and adopting technology to improve the quality of their services and lower their operating expenses.

Digital health start-ups raised $21.30 billion in the first nine months of 2021, 46.9% higher than the $14.30 billion raised in its fiscal 2022. Given the increased adoption of artificial intelligence, machine learning, and data analytics, the health tech market is poised to maintain this growth trajectory in the current year. Merck Global Health Innovation Fund's Bill Taranto said, "In 2022, entrepreneurs and investors will expand telemedicine into more chronic care spaces like cardiology…Overall, expect telehealth players to build out their offerings across the chronic care landscape in a meaningful way in 2022."

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.